The Biotechnology Industry Organization (BIO) will be holding its Intellectual Property Counsels' Committee (IPCC) Spring Conference & Meeting on March 25-27, 2009 in Phoenix, AZ. The semi-annual IPCC conference will be open to the public for the first time ever. The registration fee for the conference ranges from $400 for BIO members to $700 for non-members. Those interested in registering can do so here or by faxing a registration form to 1-202-488-0650. An agenda for the conference can be found here. Additional information can be found at the conference website.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Recent Posts
- Recor Medical, Inc. v. Medtronic Ireland Mfg. (Fed. Cir. 2025)
- Newman v. Moore -- Down to a "Battle of the Experts"?
- Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (Fed. Cir. 2025)
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
- DNA Genotek Inc. v. Spectrum Solutions LLC (Fed. Cir. 2025)
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
- Five Years Ago Today . . .
- President Nominates John Squires to be Next USPTO Director
- Immunogen, Inc. v. Stewart (Fed. Cir. 2025)
- Judge Newman Files Reply Brief in Newman v. Moore
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Document Management, E-Discovery, and Litigation Readiness for Life Sciences Conference | Main | USPTO News: Agenda for Next BCP Meeting »
February 06, 2009
The comments to this entry are closed.
April 2025
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 |
Categories
- Artificial Intelligence (19)
- Best Mode (2)
- Biosimilars (247)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (278)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (107)
- Conferences & CLE's (2977)
- Copyright (4)
- Court Report (507)
- Damages (37)
- Definiteness (27)
- District Court (223)
- Double Patenting (42)
- Enablement (52)
- Federal Circuit (1036)
- Food and Drug Administration (112)
- Hatch-Waxman (96)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (28)
- Infringement - Literal or DOE (92)
- Injunction (39)
- International IP (297)
- Inventorship (17)
- Licensing (129)
- Media Commentary (71)
- Miscellaneous (169)
- News from Abroad (102)
- Novelty (74)
- Obviousness (237)
- Patent Exhaustion (3)
- Patent Legislation (312)
- Patent Litigation (217)
- Patent Office Rules & Procedures (833)
- Patent Profiles (104)
- Patent Prosecution (99)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (371)
- Patentable Subject Matter (645)
- Personalized Medicine (5)
- Post-Grant Proceedings (158)
- PTAB Report (9)
- Study/Report (8)
- Supreme Court (265)
- Tools (5)
- Trade Secrets (13)
- Utility (4)
- Venue (11)
- Written Description (90)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments